Equities

Aso International Inc

9340:TYO

Aso International Inc

Actions
Health CareMedical Equipment and Services
  • Price (JPY)1,128.00
  • Today's Change-62.00 / -5.21%
  • Shares traded58.60k
  • 1 Year change+86.75%
  • Beta--
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Dividends in JPY

In 2024, Aso International Inc reported a dividend of 35.00 JPY, which represents a 66.67% increase over last year. The analyst covering the company expects dividends of 40.00 JPY for the upcoming fiscal year, an increase of 14.29%.
Div growth (TTM)66.67%
More ▼

Earnings history & estimates in JPY

Aso International Inc reported annual 2024 earnings of 79.51 per share on Aug 13, 2024.
Average growth rate+4.46%
More ▼

Revenue history & estimates in JPY

Aso International Inc had 1st quarter 2025 revenues of 916.00k. This bettered the 910.00k estimate of the one analyst covering the company. This was 6.26% above the prior year's 1st quarter results.
Average growth rate+1.65%
Aso International Inc had revenues for the full year 2024 of 3.54m. This was 11.10% above the prior year's results.
Average growth rate+11.10%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.